Works by Powell, Christine


Results: 65
    1
    2
    3
    4

    Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).

    Published in:
    Cardiovascular Drugs & Therapy, 2020, v. 34, n. 3, p. 357, doi. 10.1007/s10557-019-06919-4
    By:
    • Judge, Daniel P.;
    • Kristen, Arnt V.;
    • Grogan, Martha;
    • Maurer, Mathew S.;
    • Falk, Rodney H.;
    • Hanna, Mazen;
    • Gillmore, Julian;
    • Garg, Pushkal;
    • Vaishnaw, Akshay K.;
    • Harrop, Jamie;
    • Powell, Christine;
    • Karsten, Verena;
    • Zhang, Xiaoping;
    • Sweetser, Marianne T.;
    • Vest, John;
    • Hawkins, Philip N.
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    The paperless office.

    Published in:
    Podiatry Now, 2009, v. 12, n. 9, p. 38
    By:
    • Powell, Christine
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Early childhood stunting and later fine motor abilities.

    Published in:
    Developmental Medicine & Child Neurology, 2010, v. 52, n. 9, p. 831, doi. 10.1111/j.1469-8749.2010.03640.x
    By:
    • CHANG, SUSAN M.;
    • WALKER, SUSAN P.;
    • GRANTHAM-MCGREGOR, SALLY;
    • POWELL, CHRISTINE A.
    Publication type:
    Article
    30
    31

    Mortality of sea lions along the central California coast linked to toxic diatom bloom.

    Published in:
    Nature, 2000, v. 403, n. 6765, p. 80, doi. 10.1038/47481
    By:
    • Scholin, Christopher A.;
    • Gulland, Frances;
    • Doucette, Gregory J.;
    • Benson, Scott;
    • Busman, Mark;
    • Chavez, Francisco P.;
    • Cordaro, Joe;
    • DeLong, Robert;
    • De Vogelaere, Andrew;
    • Harvey, James;
    • Haulena, Martin;
    • Lefebvre, Kathi;
    • Lipscomb, Tom;
    • Loscutoff, Susan;
    • Lowenstine, Linda J.;
    • Marin III, Roman;
    • Miller, Peter E.;
    • McLellan, William A.;
    • Moeller, Peter D.R.;
    • Powell, Christine L.
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    47

    A randomised, factorial phase II study to determine the optimal dosing regimen for 68Ga-satoreotide trizoxetan as an imaging agent in patients with gastroenteropancreatic neuroendocrine tumours.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261936
    By:
    • Virgolini, Irene;
    • Bahri, Shadfar;
    • Kjaer, Andreas;
    • Grønbæk, Henning;
    • Iversen, Peter;
    • Carlsen, Esben A.;
    • Loft, Mathias;
    • Knigge, Ulrich;
    • Maffey-Steffan, Johanna;
    • Powell, Christine;
    • Miller, Colin G.;
    • Rohban, Thomas;
    • McEwan, Sandy;
    • Czernin, Johannes
    Publication type:
    Article
    48

    A randomised, factorial phase II study to determine the optimal dosing regimen for <sup>68</sup>Ga-satoreotide trizoxetan as an imaging agent in patients with gastroenteropancreatic neuroendocrine tumours.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.261936
    By:
    • Virgolini, Irene;
    • Bahri, Shadfar;
    • Kjaer, Andreas;
    • Grønbæk, Henning;
    • Iversen, Peter;
    • Carlsen, Esben A.;
    • Loft, Mathias;
    • Knigge, Ulrich;
    • Maffey-Steffan, Johanna;
    • Powell, Christine;
    • Miller, Colin G.;
    • Rohban, Thomas;
    • McEwan, Sandy;
    • Czernin, Johannes
    Publication type:
    Article
    49

    A randomised, factorial phase II study to determine the optimal dosing regimen for <sup>68</sup>Ga-satoreotide trizoxetan as an imaging agent in patients with gastroenteropancreatic neuroendocrine tumours.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.261936
    By:
    • Virgolini, Irene;
    • Bahri, Shadfar;
    • Kjaer, Andreas;
    • Grønbæk, Henning;
    • Iversen, Peter;
    • Carlsen, Esben A.;
    • Loft, Mathias;
    • Knigge, Ulrich;
    • Maffey-Steffan, Johanna;
    • Powell, Christine;
    • Miller, Colin G.;
    • Rohban, Thomas;
    • McEwan, Sandy;
    • Czernin, Johannes
    Publication type:
    Article
    50

    A randomised, factorial phase II study to determine the optimal dosing regimen for <sup>68</sup>Ga-satoreotide trizoxetan as an imaging agent in patients with gastroenteropancreatic neuroendocrine tumours.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.261936
    By:
    • Virgolini, Irene;
    • Bahri, Shadfar;
    • Kjaer, Andreas;
    • Grønbæk, Henning;
    • Iversen, Peter;
    • Carlsen, Esben A.;
    • Loft, Mathias;
    • Knigge, Ulrich;
    • Maffey-Steffan, Johanna;
    • Powell, Christine;
    • Miller, Colin G.;
    • Rohban, Thomas;
    • McEwan, Sandy;
    • Czernin, Johannes
    Publication type:
    Article